Patents by Inventor B. Lynn Allen-Hoffman

B. Lynn Allen-Hoffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human skin equivalents expressing exogenous polypeptides
    Patent number: 10918768
    Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: February 16, 2021
    Assignee: Stratatech Corporation
    Inventors: John M. Centanni, B. Lynn Allen-Hoffman
  • HUMAN SKIN EQUIVALENTS EXPRESSING EXOGENOUS POLYPEPTIDES
    Publication number: 20180311414
    Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Application
    Filed: July 16, 2018
    Publication date: November 1, 2018
    Inventors: John M. Centanni, B. Lynn Allen-Hoffman
  • HUMAN SKIN EQUIVALENTS EXPRESSING EXOGENOUS POLYPEPTIDES
    Publication number: 20170157297
    Abstract: The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
    Type: Application
    Filed: December 13, 2016
    Publication date: June 8, 2017
    Inventors: John M. Centanni, B. Lynn Allen-Hoffman